Abbott Labs Skids On Light Earnings Guidance Despite Quarterly Sales BeatInvestors Business Daily • 01/24/24
Abbott Labs battles negative Covid-19 comparables but hits earnings targetsProactive Investors • 01/24/24
Abbott Labs' fourth-quarter sales top estimates amid strong medical-device demandMarket Watch • 01/24/24
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial OutlookPRNewsWire • 01/24/24
Seeking Clues to Abbott (ABT) Q4 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 01/19/24
Abbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsPRNewsWire • 01/18/24
Abbott Laboratories (ABT) 42nd Annual J.P. Morgan Healthcare Conference Call TranscriptSeeking Alpha • 01/09/24
Tandem Diabetes Care's t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott's New FreeStyle Libre® 2 Plus SensorBusiness Wire • 01/08/24
Ozempic and other weight-loss drugs' popularity set these stocks up for big gainsMarket Watch • 01/04/24
Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensiveCNBC • 12/28/23